<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p221" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_221{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_221{left:306px;bottom:30px;}
#t3_221{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_221{left:346px;bottom:30px;}
#t5_221{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_221{left:517px;bottom:30px;}
#t7_221{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_221{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_221{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_221{left:1115px;bottom:27px;letter-spacing:0.23px;}
#tb_221{left:35px;bottom:777px;letter-spacing:0.14px;word-spacing:0.05px;}
#tc_221{left:35px;bottom:759px;letter-spacing:0.1px;word-spacing:-0.09px;}
#td_221{left:35px;bottom:739px;letter-spacing:0.04px;word-spacing:0.15px;}
#te_221{left:35px;bottom:720px;letter-spacing:0.16px;}
#tf_221{left:396px;bottom:720px;}
#tg_221{left:35px;bottom:683px;letter-spacing:0.18px;}
#th_221{left:35px;bottom:665px;letter-spacing:0.05px;word-spacing:0.13px;}
#ti_221{left:35px;bottom:645px;letter-spacing:0.11px;word-spacing:0.08px;}
#tj_221{left:35px;bottom:625px;letter-spacing:0.16px;}
#tk_221{left:386px;bottom:625px;}
#tl_221{left:35px;bottom:589px;letter-spacing:0.08px;word-spacing:0.11px;}
#tm_221{left:35px;bottom:570px;letter-spacing:0.07px;word-spacing:-0.98px;}
#tn_221{left:35px;bottom:551px;letter-spacing:0.05px;word-spacing:-0.32px;}
#to_221{left:35px;bottom:531px;letter-spacing:0.08px;word-spacing:0.11px;}
#tp_221{left:35px;bottom:512px;letter-spacing:0.16px;}
#tq_221{left:396px;bottom:512px;}
#tr_221{left:35px;bottom:476px;letter-spacing:0.11px;word-spacing:0.08px;}
#ts_221{left:35px;bottom:457px;letter-spacing:0.03px;word-spacing:-0.71px;}
#tt_221{left:35px;bottom:437px;letter-spacing:0.06px;word-spacing:0.13px;}
#tu_221{left:35px;bottom:418px;letter-spacing:0.09px;word-spacing:0.09px;}
#tv_221{left:35px;bottom:398px;letter-spacing:0.15px;}
#tw_221{left:376px;bottom:398px;}
#tx_221{left:35px;bottom:363px;letter-spacing:0.11px;word-spacing:-0.45px;}
#ty_221{left:35px;bottom:343px;letter-spacing:0.12px;word-spacing:-0.17px;}
#tz_221{left:35px;bottom:324px;letter-spacing:0.07px;word-spacing:0.11px;}
#t10_221{left:35px;bottom:304px;letter-spacing:-0.38px;}
#t11_221{left:59px;bottom:304px;letter-spacing:0.16px;}
#t12_221{left:409px;bottom:304px;}
#t13_221{left:35px;bottom:269px;letter-spacing:0.08px;word-spacing:0.11px;}
#t14_221{left:35px;bottom:249px;letter-spacing:0.11px;word-spacing:0.07px;}
#t15_221{left:35px;bottom:229px;letter-spacing:0.06px;word-spacing:-0.56px;}
#t16_221{left:35px;bottom:210px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t17_221{left:132px;bottom:210px;letter-spacing:0.16px;}
#t18_221{left:483px;bottom:210px;}
#t19_221{left:35px;bottom:174px;letter-spacing:0.04px;word-spacing:0.14px;}
#t1a_221{left:35px;bottom:155px;letter-spacing:0.04px;word-spacing:0.14px;}
#t1b_221{left:35px;bottom:135px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1c_221{left:35px;bottom:116px;letter-spacing:0.06px;word-spacing:0.13px;}
#t1d_221{left:35px;bottom:96px;letter-spacing:0.16px;}
#t1e_221{left:386px;bottom:96px;}
#t1f_221{left:618px;bottom:777px;letter-spacing:0.14px;word-spacing:0.04px;}
#t1g_221{left:618px;bottom:759px;letter-spacing:0.05px;word-spacing:0.14px;}
#t1h_221{left:618px;bottom:739px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1i_221{left:618px;bottom:720px;letter-spacing:0.11px;word-spacing:0.07px;}
#t1j_221{left:618px;bottom:700px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t1k_221{left:715px;bottom:700px;letter-spacing:0.16px;}
#t1l_221{left:1066px;bottom:700px;}
#t1m_221{left:618px;bottom:665px;letter-spacing:0.1px;word-spacing:-0.16px;}
#t1n_221{left:618px;bottom:645px;letter-spacing:0.11px;word-spacing:0.08px;}
#t1o_221{left:618px;bottom:625px;letter-spacing:0.11px;word-spacing:0.07px;}
#t1p_221{left:618px;bottom:606px;letter-spacing:0.16px;}
#t1q_221{left:969px;bottom:606px;}
#t1r_221{left:618px;bottom:570px;letter-spacing:0.11px;word-spacing:0.08px;}
#t1s_221{left:618px;bottom:551px;letter-spacing:0.03px;word-spacing:-0.77px;}
#t1t_221{left:618px;bottom:531px;letter-spacing:0.11px;word-spacing:-1.01px;}
#t1u_221{left:618px;bottom:512px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t1v_221{left:715px;bottom:512px;letter-spacing:0.16px;}
#t1w_221{left:1066px;bottom:512px;}
#t1x_221{left:618px;bottom:476px;letter-spacing:0.03px;word-spacing:0.15px;}
#t1y_221{left:618px;bottom:457px;letter-spacing:0.09px;word-spacing:0.09px;}
#t1z_221{left:618px;bottom:437px;letter-spacing:0.04px;word-spacing:0.15px;}
#t20_221{left:618px;bottom:418px;letter-spacing:0.07px;word-spacing:0.12px;}
#t21_221{left:618px;bottom:398px;letter-spacing:0.16px;}
#t22_221{left:979px;bottom:398px;}
#t23_221{left:618px;bottom:363px;letter-spacing:0.14px;word-spacing:0.04px;}
#t24_221{left:618px;bottom:343px;letter-spacing:0.12px;word-spacing:0.07px;}
#t25_221{left:618px;bottom:324px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t26_221{left:715px;bottom:324px;letter-spacing:0.16px;}
#t27_221{left:1066px;bottom:324px;}
#t28_221{left:618px;bottom:288px;letter-spacing:0.05px;word-spacing:0.02px;}
#t29_221{left:618px;bottom:269px;letter-spacing:0.06px;word-spacing:0.02px;}
#t2a_221{left:618px;bottom:249px;letter-spacing:0.04px;word-spacing:0.29px;}
#t2b_221{left:618px;bottom:229px;letter-spacing:0.08px;word-spacing:0.1px;}
#t2c_221{left:618px;bottom:210px;letter-spacing:0.16px;}
#t2d_221{left:969px;bottom:210px;}
#t2e_221{left:618px;bottom:174px;letter-spacing:0.11px;word-spacing:-0.79px;}
#t2f_221{left:618px;bottom:155px;letter-spacing:0.06px;word-spacing:0.13px;}
#t2g_221{left:618px;bottom:135px;letter-spacing:0.02px;word-spacing:0.17px;}
#t2h_221{left:618px;bottom:116px;letter-spacing:0.09px;word-spacing:0.11px;}
#t2i_221{left:618px;bottom:96px;letter-spacing:0.08px;word-spacing:0.1px;}
#t2j_221{left:618px;bottom:77px;letter-spacing:0.16px;}
#t2k_221{left:979px;bottom:77px;}
#t2l_221{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_221{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_221{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_221{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_221{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_221{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_221{font-size:17px;font-family:ArialMT_5tg;color:#005B99;}
.s6_221{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts221" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg221Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg221" style="-webkit-user-select: none;"><object width="1210" height="935" data="221/221.svg" type="image/svg+xml" id="pdf221" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_221" class="t s0_221">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_221" class="t s1_221">© </span>
<span id="t3_221" class="t s0_221">(NCCN </span>
<span id="t4_221" class="t s1_221">© </span>
<span id="t5_221" class="t s0_221">), All rights reserved. NCCN Guidelines </span>
<span id="t6_221" class="t s1_221">® </span>
<span id="t7_221" class="t s0_221">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_221" class="t s2_221">NCCN Guidelines Version 4.2024 </span>
<span id="t9_221" class="t s2_221">Head and Neck Cancers </span>
<span id="ta_221" class="t s3_221">MS-80 </span>
<span id="tb_221" class="t s4_221">262. Tell R, Lundell G, Nilsson B, et al. Long-term incidence of </span>
<span id="tc_221" class="t s4_221">hypothyroidism after radiotherapy in patients with head-and-neck cancer. </span>
<span id="td_221" class="t s4_221">Int J Radiat Oncol Biol Phys 2004;60:395-400. Available at: </span>
<span id="te_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/15380571</span><span id="tf_221" class="t s4_221">. </span>
<span id="tg_221" class="t s4_221">263. Posner MR, Ervin TJ, Miller D, et al. Incidence of hypothyroidism </span>
<span id="th_221" class="t s4_221">following multimodality treatment for advanced squamous cell cancer of </span>
<span id="ti_221" class="t s4_221">the head and neck. Laryngoscope 1984;94:451-454. Available at: </span>
<span id="tj_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/6708688</span><span id="tk_221" class="t s4_221">. </span>
<span id="tl_221" class="t s4_221">264. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III </span>
<span id="tm_221" class="t s4_221">comparison of standard radiation therapy and two schedules of concurrent </span>
<span id="tn_221" class="t s4_221">chemoradiotherapy in patients with unresectable squamous cell head and </span>
<span id="to_221" class="t s4_221">neck cancer. J Clin Oncol 2003;21:92-98. Available at: </span>
<span id="tp_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/12506176</span><span id="tq_221" class="t s4_221">. </span>
<span id="tr_221" class="t s4_221">265. Lo TC, Wiley AL, Jr., Ansfield FJ, et al. Combined radiation therapy </span>
<span id="ts_221" class="t s4_221">and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity </span>
<span id="tt_221" class="t s4_221">and oropharynx: a randomized study. AJR Am J Roentgenol </span>
<span id="tu_221" class="t s4_221">1976;126:229-235. Available at: </span>
<span id="tv_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/175693</span><span id="tw_221" class="t s4_221">. </span>
<span id="tx_221" class="t s4_221">266. Sanchiz F, Milla A, Torner J, et al. Single fraction per day versus two </span>
<span id="ty_221" class="t s4_221">fractions per day versus radiochemotherapy in the treatment of head and </span>
<span id="tz_221" class="t s4_221">neck cancer. Int J Radiat Oncol Biol Phys 1990;19:1347-1350. Available </span>
<span id="t10_221" class="t s4_221">at: </span><span id="t11_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/2262356</span><span id="t12_221" class="t s4_221">. </span>
<span id="t13_221" class="t s4_221">267. Browman GP, Cripps C, Hodson DI, et al. Placebo-controlled </span>
<span id="t14_221" class="t s4_221">randomized trial of infusional fluorouracil during standard radiotherapy in </span>
<span id="t15_221" class="t s4_221">locally advanced head and neck cancer. J Clin Oncol 1994;12:2648-2653. </span>
<span id="t16_221" class="t s4_221">Available at: </span><span id="t17_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/7989940</span><span id="t18_221" class="t s4_221">. </span>
<span id="t19_221" class="t s4_221">268. Smid L, Lesnicar H, Zakotnik B, et al. Radiotherapy, combined with </span>
<span id="t1a_221" class="t s4_221">simultaneous chemotherapy with mitomycin C and bleomycin for </span>
<span id="t1b_221" class="t s4_221">inoperable head and neck cancer--preliminary report. Int J Radiat Oncol </span>
<span id="t1c_221" class="t s4_221">Biol Phys 1995;32:769-775. Available at: </span>
<span id="t1d_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/7540606</span><span id="t1e_221" class="t s4_221">. </span>
<span id="t1f_221" class="t s4_221">269. Merlano M, Benasso M, Corvo R, et al. Five-year update of a </span>
<span id="t1g_221" class="t s4_221">randomized trial of alternating radiotherapy and chemotherapy compared </span>
<span id="t1h_221" class="t s4_221">with radiotherapy alone in treatment of unresectable squamous cell </span>
<span id="t1i_221" class="t s4_221">carcinoma of the head and neck. J Natl Cancer Inst 1996;88:583-589. </span>
<span id="t1j_221" class="t s4_221">Available at: </span><span id="t1k_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/8609658</span><span id="t1l_221" class="t s4_221">. </span>
<span id="t1m_221" class="t s4_221">270. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation </span>
<span id="t1n_221" class="t s4_221">with or without concurrent chemotherapy for locally advanced head and </span>
<span id="t1o_221" class="t s4_221">neck cancer. N Engl J Med 1998;338:1798-1804. Available at: </span>
<span id="t1p_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/9632446</span><span id="t1q_221" class="t s4_221">. </span>
<span id="t1r_221" class="t s4_221">271. Wendt TG, Grabenbauer GG, Rodel CM, et al. Simultaneous </span>
<span id="t1s_221" class="t s4_221">radiochemotherapy versus radiotherapy alone in advanced head and neck </span>
<span id="t1t_221" class="t s4_221">cancer: a randomized multicenter study. J Clin Oncol 1998;16:1318-1324. </span>
<span id="t1u_221" class="t s4_221">Available at: </span><span id="t1v_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/9552032</span><span id="t1w_221" class="t s4_221">. </span>
<span id="t1x_221" class="t s4_221">272. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation </span>
<span id="t1y_221" class="t s4_221">therapy with or without concurrent low-dose daily cisplatin in locally </span>
<span id="t1z_221" class="t s4_221">advanced squamous cell carcinoma of the head and neck: a prospective </span>
<span id="t20_221" class="t s4_221">randomized trial. J Clin Oncol 2000;18:1458-1464. Available at: </span>
<span id="t21_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/10735893</span><span id="t22_221" class="t s4_221">. </span>
<span id="t23_221" class="t s4_221">273. Munro AJ. An overview of randomised controlled trials of adjuvant </span>
<span id="t24_221" class="t s4_221">chemotherapy in head and neck cancer. Br J Cancer 1995;71:83-91. </span>
<span id="t25_221" class="t s4_221">Available at: </span><span id="t26_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/7819055</span><span id="t27_221" class="t s4_221">. </span>
<span id="t28_221" class="t s4_221">274. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the </span>
<span id="t29_221" class="t s4_221">management of squamous cell carcinoma of the head and neck region. A </span>
<span id="t2a_221" class="t s4_221">meta-analysis of prospective and randomized trials. J Clin Oncol </span>
<span id="t2b_221" class="t s4_221">1996;14:838-847. Available at: </span>
<span id="t2c_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/8622032</span><span id="t2d_221" class="t s4_221">. </span>
<span id="t2e_221" class="t s4_221">275. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added </span>
<span id="t2f_221" class="t s4_221">to locoregional treatment for head and neck squamous-cell carcinoma: </span>
<span id="t2g_221" class="t s4_221">three meta-analyses of updated individual data. MACH-NC Collaborative </span>
<span id="t2h_221" class="t s4_221">Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. </span>
<span id="t2i_221" class="t s4_221">Lancet 2000;355:949-955. Available at: </span>
<span id="t2j_221" class="t s5_221">http://www.ncbi.nlm.nih.gov/pubmed/10768432</span><span id="t2k_221" class="t s4_221">. </span>
<span id="t2l_221" class="t s6_221">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
